NeoadjuvantTherapyDisease-FreeSurvivalRateHER-2BRCAGenePhyllodesTumorCachexiaER+OvarianSuppressionRelapseGermlineMutationMegestrolAcetateBilateralProphylacticMastectomyMetastaticBreastCancerRadiotherapyIn-situCarcinomaLymphNodeStatusAdjuvantTherapyMethotrexateGailModelCheckpointInhibitorDocetaxelBevacizumabKi-67RateApoptosisDiabeticMastopathyCytotoxicChemopreventionMRIAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerAntiemeticFlowCytometryLumpAdvocacyFISHEvidencesuggests thatphysical activitymay reduce therisk of breastcancersPathologicResponseRADStagingDoxorubicinLCISMastectomyCMFChemotherapyBI-RADSSelf-examinationIntraductalPapilloma1 in 8womenAlopeciaEndometrialCancerBenignPhyllodesTumorOligometastasesBreastTomosynthesisGeneticPredispositionGeneMutationDown-StagingCAMMetastasisCDK4/6InhibitorsPalbociclibBrachytherapyLymphoscintigraphyDimplingMastitisHormoneReceptorStatusMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be felt5-FluorouracilAngiogenesisNodeNegativeAntibodyTherapyGenomicTestingPARPInhibitorsExcisionalBiopsyMastalgiaPaclitaxelNeoplasmEstradiolWomen ages40+ shouldhave a clinicalbreast examat least yearlyTamoxifenCystMultifocalTumorsAbsoluteRiskMultimodalityTherapyER-ChemotherapyOophorectomyInvasiveBreastCancerMolecularBreastImagingKappaEpsilonFibroadenomaSERMAdenocarcinomaPalpationGeneticCounselingWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.Tyrosine-KinaseInhibitorEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearBreastCancerBiopsyAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenCytostaticLapatinibNodePositiveFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.CyclophosphamideProgestinAyurvedaSclerosingAdenosisPI3KinaseInhibitorsPrecisionMedicineACChemotherapyMorpheaTriplePositiveBreastCancerCapecitabinePagetDiseaseDoseDenseTherapyMastodyniaCo-survivorBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55ImmunotherapyRaloxifeneHormoneReplacementTherapylatissimusflapEstrogenAxillarySamplingDefinitiveSurgeryECOGScoremTORInhibitorsFamilyHistoryTripleNegativeBreastCancerLiquidBiopsyAromataseInhibitorsTumorGradeLumpectomyCalcificationsBOCAHerceptinAnastrozoleEGFR(epidermalgrowth factorreceptor)GuaranteedRenewableInsuranceNeoadjuvantTherapyDisease-FreeSurvivalRateHER-2BRCAGenePhyllodesTumorCachexiaER+OvarianSuppressionRelapseGermlineMutationMegestrolAcetateBilateralProphylacticMastectomyMetastaticBreastCancerRadiotherapyIn-situCarcinomaLymphNodeStatusAdjuvantTherapyMethotrexateGailModelCheckpointInhibitorDocetaxelBevacizumabKi-67RateApoptosisDiabeticMastopathyCytotoxicChemopreventionMRIAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerAntiemeticFlowCytometryLumpAdvocacyFISHEvidencesuggests thatphysical activitymay reduce therisk of breastcancersPathologicResponseRADStagingDoxorubicinLCISMastectomyCMFChemotherapyBI-RADSSelf-examinationIntraductalPapilloma1 in 8womenAlopeciaEndometrialCancerBenignPhyllodesTumorOligometastasesBreastTomosynthesisGeneticPredispositionGeneMutationDown-StagingCAMMetastasisCDK4/6InhibitorsPalbociclibBrachytherapyLymphoscintigraphyDimplingMastitisHormoneReceptorStatusMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be felt5-FluorouracilAngiogenesisNodeNegativeAntibodyTherapyGenomicTestingPARPInhibitorsExcisionalBiopsyMastalgiaPaclitaxelNeoplasmEstradiolWomen ages40+ shouldhave a clinicalbreast examat least yearlyTamoxifenCystMultifocalTumorsAbsoluteRiskMultimodalityTherapyER-ChemotherapyOophorectomyInvasiveBreastCancerMolecularBreastImagingKappaEpsilonFibroadenomaSERMAdenocarcinomaPalpationGeneticCounselingWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.Tyrosine-KinaseInhibitorEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearBreastCancerBiopsyAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenCytostaticLapatinibNodePositiveFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.CyclophosphamideProgestinAyurvedaSclerosingAdenosisPI3KinaseInhibitorsPrecisionMedicineACChemotherapyMorpheaTriplePositiveBreastCancerCapecitabinePagetDiseaseDoseDenseTherapyMastodyniaCo-survivorBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55ImmunotherapyRaloxifeneHormoneReplacementTherapylatissimusflapEstrogenAxillarySamplingDefinitiveSurgeryECOGScoremTORInhibitorsFamilyHistoryTripleNegativeBreastCancerLiquidBiopsyAromataseInhibitorsTumorGradeLumpectomyCalcificationsBOCAHerceptinAnastrozoleEGFR(epidermalgrowth factorreceptor)GuaranteedRenewableInsurance

BOCA Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
  1. Neoadjuvant Therapy
  2. Disease-Free Survival Rate
  3. HER-2
  4. BRCA Gene
  5. Phyllodes Tumor
  6. Cachexia
  7. ER+
  8. Ovarian Suppression
  9. Relapse
  10. Germline Mutation
  11. Megestrol Acetate
  12. Bilateral Prophylactic Mastectomy
  13. Metastatic Breast Cancer
  14. Radiotherapy
  15. In-situ Carcinoma
  16. Lymph Node Status
  17. Adjuvant Therapy
  18. Methotrexate
  19. Gail Model
  20. Checkpoint Inhibitor
  21. Docetaxel
  22. Bevacizumab
  23. Ki-67 Rate
  24. Apoptosis
  25. Diabetic Mastopathy
  26. Cytotoxic
  27. Chemoprevention
  28. MRI
  29. Alcohol intake of more than two drinks per day is a risk factor for breast cancer
  30. Antiemetic
  31. Flow Cytometry
  32. Lump
  33. Advocacy
  34. FISH
  35. Evidence suggests that physical activity may reduce the risk of breast cancers
  36. Pathologic Response
  37. RAD
  38. Staging
  39. Doxorubicin
  40. LCIS
  41. Mastectomy
  42. CMF Chemotherapy
  43. BI-RADS
  44. Self-examination
  45. Intraductal Papilloma
  46. 1 in 8 women
  47. Alopecia
  48. Endometrial Cancer
  49. Benign Phyllodes Tumor
  50. Oligometastases
  51. Breast Tomosynthesis
  52. Genetic Predisposition
  53. Gene Mutation
  54. Down-Staging
  55. CAM
  56. Metastasis
  57. CDK4/6 Inhibitors
  58. Palbociclib
  59. Brachytherapy
  60. Lymphoscintigraphy
  61. Dimpling
  62. Mastitis
  63. Hormone Receptor Status
  64. Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt
  65. 5-Fluorouracil
  66. Angiogenesis
  67. Node Negative
  68. Antibody Therapy
  69. Genomic Testing
  70. PARP Inhibitors
  71. Excisional Biopsy
  72. Mastalgia
  73. Paclitaxel
  74. Neoplasm
  75. Estradiol
  76. Women ages 40+ should have a clinical breast exam at least yearly
  77. Tamoxifen
  78. Cyst
  79. Multifocal Tumors
  80. Absolute Risk
  81. Multimodality Therapy
  82. ER-
  83. Chemotherapy
  84. Oophorectomy
  85. Invasive Breast Cancer
  86. Molecular Breast Imaging
  87. Kappa Epsilon
  88. Fibroadenoma
  89. SERM
  90. Adenocarcinoma
  91. Palpation
  92. Genetic Counseling
  93. Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
  94. Tyrosine-Kinase Inhibitor
  95. Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year
  96. Breast Cancer
  97. Biopsy
  98. African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
  99. Cytostatic
  100. Lapatinib
  101. Node Positive
  102. For every 1,000 screening mammograms performed, about five breast cancers are detected.
  103. Cyclophosphamide
  104. Progestin
  105. Ayurveda
  106. Sclerosing Adenosis
  107. PI3 Kinase Inhibitors
  108. Precision Medicine
  109. AC Chemotherapy
  110. Morphea
  111. Triple Positive Breast Cancer
  112. Capecitabine
  113. Paget Disease
  114. Dose Dense Therapy
  115. Mastodynia
  116. Co-survivor
  117. Breast cancer is the leading cause of death in women between the ages of 40 and 55
  118. Immunotherapy
  119. Raloxifene
  120. Hormone Replacement Therapy
  121. latissimus flap
  122. Estrogen
  123. Axillary Sampling
  124. Definitive Surgery
  125. ECOG Score
  126. mTOR Inhibitors
  127. Family History
  128. Triple Negative Breast Cancer
  129. Liquid Biopsy
  130. Aromatase Inhibitors
  131. Tumor Grade
  132. Lumpectomy
  133. Calcifications
  134. BOCA
  135. Herceptin
  136. Anastrozole
  137. EGFR (epidermal growth factor receptor)
  138. Guaranteed Renewable Insurance